The Pharma Congress Production & Technology
The Pharma Congress Production & Technology has been Germany's leading convention in the pharma environment for 11 years, combining high-class special subject matter conferences, an adjacent exhibition and directly connected hotel accommodation. Last year, nearly 400 delegates, exhibitors and visitors attended.
The Pharma Congress Production & Technology has been Germany's leading convention in the pharma environment for 11 years, combining high-class special subject matter conferences, an adjacent exhibition and directly connected hotel accommodation. Last year, nearly 400 delegates, exhibitors and visitors attended.
For 2010, the Pharma Congress has been completely revised, introducing a number of innovations: this year, it will be comprised of seven conferences, two of which are the international events "Barrier Systems" and "Current Aseptic Technologies" conducted in cooperation with the European Compliance Academy (ECA). Moreover, rather than registering for a single conference, for the first time delegates will be able to buy daily tickets for 490 Euros, enabling them to attend any of the lectures of all conferences on that specific congress day.
In addition to the conferences, the Congress also provides delegates with the opportunity to get the latest information on new technologies, products and services at the parallel exhibition. This year, more than 70 internationally oriented exhibitors registered. This exhibition will also be open free of charge to visitors not attending any of conferences. To be able to only visit the exhibition, though, it will be necessary to register online in advance.
The Pharma Congress 2010 will take place in Duessseldorf/Neuss, Germany, from 9-10 March 2010. To find out more about this industry meeting point please visit www.pharma-kongress.com.
ContactCONCEPT HEIDELBERG
Rischerstrasse 8
69123 Heidelberg
Germany
Phone: +49 6221 84 44-0
E-Mail: ref="mailto:info@concept-heidelberg.de" target="_blank">info@concept-heidelberg.de
ref="http://www.gmp-navigator.com" target="_blank">www.gmp-navigator.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
